FK
Therapeutic Areas
Tulavi Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| allay Hydrogel Cap | Reduction of risk of symptomatic neuroma formation after peripheral nerve transection | Commercial |
| Drug | Indication | Phase |
|---|---|---|
| allay Hydrogel Cap | Reduction of risk of symptomatic neuroma formation after peripheral nerve transection | Commercial |